Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$8.75 - $30.71 $226,800 - $796,003
-25,920 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$22.96 - $30.13 $595,123 - $780,969
25,920 New
25,920 $714,000
Q1 2021

May 17, 2021

SELL
$27.81 - $53.64 $292,005 - $563,220
-10,500 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$37.09 - $54.5 $389,445 - $572,250
10,500 New
10,500 $505,000

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $179M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.